Shenzhen Hepalink Pharmaceutical Co Ltd (002399) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Based on the latest financial reports, Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥399.43 Million ≈ $58.45 Million USD) by net assets (CN¥12.43 Billion ≈ $1.82 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shenzhen Hepalink Pharmaceutical Co Ltd (002399) total market value for the company's overall valuation and market capitalisation.

Shenzhen Hepalink Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Shenzhen Hepalink Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shenzhen Hepalink Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Hepalink Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Shenzhen Hepalink Pharmaceutical Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Mirae Asset Life Insurance Co Ltd KO:085620	0.219x
ANI Pharmaceuticals Inc NASDAQ:ANIP	0.056x
Chongqing Zaisheng Tech Corp SHG:603601	0.066x
Harbin Boshi Automation Co Ltd SHE:002698	0.010x
Jiangsu Cai Qin Technology Co Ltd SHG:688182	-0.002x
Akr Corporindo Tbk JK:AKRA	0.157x
Dongsuh KO:026960	0.006x
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	0.070x

Annual Cash Flow Conversion Efficiency for Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shenzhen Hepalink Pharmaceutical Co Ltd from 2006 to 2025. View today's stock price for Shenzhen Hepalink Pharmaceutical Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥12.08 Billion ≈ $1.77 Billion	CN¥1.71 Billion ≈ $250.66 Million	0.142x	-21.14%
2024-12-31	CN¥12.20 Billion ≈ $1.79 Billion	CN¥2.19 Billion ≈ $321.07 Million	0.180x	+441.34%
2023-12-31	CN¥11.99 Billion ≈ $1.75 Billion	CN¥398.22 Million ≈ $58.27 Million	0.033x	+154.47%
2022-12-31	CN¥12.41 Billion ≈ $1.82 Billion	CN¥-756.61 Million ≈ $-110.72 Million	-0.061x	-10499.68%
2021-12-31	CN¥11.52 Billion ≈ $1.69 Billion	CN¥-6.63 Million ≈ $-970.08K	-0.001x	-118.04%
2020-12-31	CN¥11.69 Billion ≈ $1.71 Billion	CN¥37.28 Million ≈ $5.46 Million	0.003x	+110.47%
2019-12-31	CN¥7.47 Billion ≈ $1.09 Billion	CN¥-227.60 Million ≈ $-33.31 Million	-0.030x	-128.48%
2018-12-31	CN¥6.24 Billion ≈ $913.80 Million	CN¥667.87 Million ≈ $97.73 Million	0.107x	+301.93%
2017-12-31	CN¥7.69 Billion ≈ $1.12 Billion	CN¥-407.12 Million ≈ $-59.57 Million	-0.053x	-223.79%
2016-12-31	CN¥8.09 Billion ≈ $1.18 Billion	CN¥346.07 Million ≈ $50.64 Million	0.043x	-57.90%
2015-12-31	CN¥8.79 Billion ≈ $1.29 Billion	CN¥893.71 Million ≈ $130.78 Million	0.102x	-7.00%
2014-12-31	CN¥8.35 Billion ≈ $1.22 Billion	CN¥912.80 Million ≈ $133.57 Million	0.109x	+109.44%
2013-12-31	CN¥8.07 Billion ≈ $1.18 Billion	CN¥420.97 Million ≈ $61.60 Million	0.052x	-11.41%
2012-12-31	CN¥8.05 Billion ≈ $1.18 Billion	CN¥473.89 Million ≈ $69.35 Million	0.059x	-66.83%
2011-12-31	CN¥7.91 Billion ≈ $1.16 Billion	CN¥1.41 Billion ≈ $205.63 Million	0.178x	+301.45%
2010-12-31	CN¥8.02 Billion ≈ $1.17 Billion	CN¥354.86 Million ≈ $51.93 Million	0.044x	-86.70%
2009-12-31	CN¥1.07 Billion ≈ $156.62 Million	CN¥355.81 Million ≈ $52.07 Million	0.332x	+155.03%
2008-12-31	CN¥307.83 Million ≈ $45.05 Million	CN¥40.13 Million ≈ $5.87 Million	0.130x	+37.85%
2007-12-31	CN¥146.44 Million ≈ $21.43 Million	CN¥13.85 Million ≈ $2.03 Million	0.095x	-87.95%
2006-12-31	CN¥91.33 Million ≈ $13.36 Million	CN¥71.66 Million ≈ $10.49 Million	0.785x	--

About Shenzhen Hepalink Pharmaceutical Co Ltd

SHE:002399 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.71 Billion

CN¥11.66 Billion CNY

Market Cap Rank

#6792 Global

#1402 in China

Share Price

CN¥9.35

Change (1 day)

-1.37%

52-Week Range

CN¥8.65 - CN¥12.56

All Time High

CN¥28.69